| scholarly article | Q13442814 |
| P356 | DOI | 10.21873/ANTICANRES.12041 |
| P698 | PubMed publication ID | 29061773 |
| P50 | author | Ahmad Najem | Q87121319 |
| Ghanem Ghanem | Q104848570 | ||
| P2093 | author name string | Ahmad Awada | |
| Fabrice Journe | |||
| Anne Perdrix | |||
| Mohammad Krayem | |||
| Joseph Kerger | |||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 5941-5953 | |
| P577 | publication date | 2017-11-01 | |
| P1433 | published in | Anticancer Research | Q326290 |
| P1476 | title | New Drug Combination Strategies in Melanoma: Current Status and Future Directions | |
| P478 | volume | 37 |
| Q58796907 | Acquired resistance to BRAFi reverses senescence-like phenotype in mutant BRAF melanoma |
| Q64970972 | Dissecting the role of RNA modification regulatory proteins in melanoma. |
| Q91754756 | Dual Kit/Aur Inhibitors as Chemosensitizing Agents for the Treatment of Melanoma: Design, Synthesis, Docking Studies and Functional Investigation |
| Q98386373 | ERK-mediated negative feedback regulation of oncogenic EGFRvIII in glioblastoma cells |
| Q92211141 | Joint action of miR-126 and MAPK/PI3K inhibitors against metastatic melanoma |
| Q98158998 | RNAi-mediated IARS2 knockdown inhibits proliferation and promotes apoptosis in human melanoma A375 cells |
| Q90239931 | Role of Macrophage Migration Inhibitory Factor (MIF) in Melanoma |
| Q64055352 | Targeting the ERK Signaling Pathway in Melanoma |
| Q89433567 | The Dual PI3K/mToR Inhibitor Omipalisib/GSK2126458 Inhibits Clonogenic Growth in Oncogenically-transformed Cells from Neurocutaneous Melanocytosis |
| Q52670598 | The value of metastasectomy in stage IV cutaneous melanoma |
Search more.